SG10201802650WA - Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives - Google Patents
Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivativesInfo
- Publication number
- SG10201802650WA SG10201802650WA SG10201802650WA SG10201802650WA SG10201802650WA SG 10201802650W A SG10201802650W A SG 10201802650WA SG 10201802650W A SG10201802650W A SG 10201802650WA SG 10201802650W A SG10201802650W A SG 10201802650WA SG 10201802650W A SG10201802650W A SG 10201802650WA
- Authority
- SG
- Singapore
- Prior art keywords
- glutarimide derivatives
- methods
- pharmaceutical composition
- composition based
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2013116826A RU2562773C3 (ru) | 2013-04-12 | Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201802650WA true SG10201802650WA (en) | 2018-05-30 |
Family
ID=51689819
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201802647QA SG10201802647QA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
| SG10201802648SA SG10201802648SA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
| SG11201508394UA SG11201508394UA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
| SG10201802650WA SG10201802650WA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201802647QA SG10201802647QA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
| SG10201802648SA SG10201802648SA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
| SG11201508394UA SG11201508394UA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
Country Status (15)
| Country | Link |
|---|---|
| US (8) | US9815814B2 (ru) |
| EP (3) | EP3722290B1 (ru) |
| JP (4) | JP6529958B2 (ru) |
| KR (3) | KR102254315B1 (ru) |
| CN (4) | CN110172055B (ru) |
| AU (5) | AU2014251442A1 (ru) |
| BR (3) | BR122020010204B1 (ru) |
| CA (1) | CA2909057C (ru) |
| EA (4) | EA032951B1 (ru) |
| IL (4) | IL266301B2 (ru) |
| MX (4) | MX2020005738A (ru) |
| SG (4) | SG10201802647QA (ru) |
| UA (1) | UA121299C2 (ru) |
| WO (1) | WO2014168522A1 (ru) |
| ZA (3) | ZA201508278B (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA032951B1 (ru) * | 2013-04-12 | 2019-08-30 | Общество С Ограниченной Ответственностью "Рсв Терапевтикс" | Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения |
| RU2552929C1 (ru) | 2013-11-14 | 2015-06-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний |
| RU2628800C2 (ru) * | 2014-03-12 | 2017-08-22 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами |
| CN106539792B (zh) * | 2016-11-07 | 2017-08-25 | 王晓旭 | 一种治疗高血脂症的药物 |
| GEP20227402B (en) * | 2017-09-07 | 2022-08-10 | Valenta Intellekt Ltd | Use of glutarimide derivative to treat diseases related to aberrant activity of cytokines |
| US20210380538A1 (en) * | 2018-11-01 | 2021-12-09 | Ahammune Biosciences Private Limited | Novel imidazole compounds, process for the synthesis and uses thereof |
| RU2712281C1 (ru) * | 2018-11-23 | 2020-01-28 | Общество С Ограниченной Ответственностью "Хемиммьюн Терапьютикс" | Применение производного глутаримида для преодоления резистентности к стероидам и терапии заболеваний, ассоциированных с аберрантным сигналингом интерферона гамма |
| MA58653B1 (fr) * | 2020-06-26 | 2024-02-29 | Valenta Intellekt Ltd | Utilisation d'un dérivé de glutarimide pour traiter des maladies liées à l'activité aberrante d'interleukine-6 |
| WO2023121519A1 (ru) * | 2021-12-23 | 2023-06-29 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Применение 1-[2-(1-метилимидазол-4-ил)-этил]пергидроазин-2,6-диона для лечения covid-19 |
| WO2023177329A1 (ru) * | 2022-03-18 | 2023-09-21 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Применение 1-(2-(1н-имидазол-4-ил)этил)пиперидин-2,6-диона для лечения кашля, вызванного вирусными инфекциями |
| WO2023191666A1 (ru) * | 2022-03-29 | 2023-10-05 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Кристаллическая форма 1-(2-(1н-имидазол-4-ил)этил)пиперидин-2,6-диона и ее применение |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3081308A (en) * | 1959-12-29 | 1963-03-12 | Searle & Co | 5-carbocyclic-3-imidomethyloxazolidines and process |
| US3171839A (en) * | 1961-05-18 | 1965-03-02 | Searle & Co | 4-alkyl-1-(cyclic imidoalkyl) piperidines |
| GB1033251A (en) * | 1961-09-07 | 1966-06-22 | Distillers Co Yeast Ltd | Glutarimide derivatives |
| US3963691A (en) * | 1974-10-07 | 1976-06-15 | Merck & Co., Inc. | Synthetic antigens of luteinizing hormone releasing hormone |
| US4261990A (en) * | 1979-03-09 | 1981-04-14 | Ciba-Geigy Corporation | N-alkyleneiminoalkyl-dicarboximides as antiallergics and antiasthmatics |
| JPS606686A (ja) * | 1983-06-27 | 1985-01-14 | Kissei Pharmaceut Co Ltd | チオフエン誘導体及びその製造方法 |
| JPS6066686A (ja) | 1983-09-19 | 1985-04-16 | Toshiba Corp | ライン駆動電動機の速度制御装置 |
| SE8600261D0 (sv) * | 1986-01-21 | 1986-01-21 | Lundblad Leif | Indolokinoxaliner med substituenter i 6-position som innehaller cykliska grupper |
| SU1836365A3 (ru) * | 1991-01-24 | 1993-08-23 | Физиko-Xиmичeckий Иhctиtуt Иm.A.B.Бoгatckoгo;Hии@ Фapmakoлoгии Poccийckoй Amh | Способ получения ν-0-пиперазинил)бутилглутаримидов |
| FR2737725B1 (fr) | 1995-08-08 | 1997-10-31 | Valentonine | Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament |
| RU2141483C1 (ru) | 1997-07-04 | 1999-11-20 | Небольсин Владимир Евгеньевич | Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция |
| EP1020447A4 (en) * | 1997-09-11 | 2000-11-15 | Nissan Chemical Ind Ltd | PYRAZOLE-BASED COMPOUNDS AND PLANT DISEASE CONTROL AGENT |
| ITMI991578A1 (it) * | 1999-07-15 | 2001-01-15 | Recordati Ind Chimica E Farma | Amidi e imidi cicliche dotate di attivita' antagonista selettiva per il recettore adrenergico |
| US6413428B1 (en) | 1999-09-16 | 2002-07-02 | Berger Instruments, Inc. | Apparatus and method for preparative supercritical fluid chromatography |
| DE10002509A1 (de) | 2000-01-21 | 2001-07-26 | Gruenenthal Gmbh | Substituierte Glutarimide |
| US7030150B2 (en) | 2001-05-11 | 2006-04-18 | Trimeris, Inc. | Benzimidazole compounds and antiviral uses thereof |
| WO2004022536A1 (en) * | 2002-09-04 | 2004-03-18 | Glenmark Pharmaceuticals Limited | New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| WO2004111031A1 (en) * | 2003-06-12 | 2004-12-23 | Novo Nordisk A/S | Pyridinyl carbamates as hormone-sensitive lipase inhibitors |
| CN1260218C (zh) * | 2003-11-06 | 2006-06-21 | 天津药物研究院 | 一类pdf酶抑制剂－异羟肟酸系列化合物及其合成方法与用途 |
| WO2006040646A1 (en) * | 2004-10-14 | 2006-04-20 | Pfizer, Inc. | Benzimidazole or indole amides as inhibitors of pin1 |
| KR100917511B1 (ko) * | 2005-02-28 | 2009-09-16 | 니뽄 다바코 산교 가부시키가이샤 | Ｓｙｋ 저해 활성을 갖는 신규한 아미노피리딘 화합물 |
| EP1741709A1 (en) * | 2005-06-28 | 2007-01-10 | Sanofi-Aventis Deutschland GmbH | Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| WO2007007054A1 (en) * | 2005-07-08 | 2007-01-18 | Cancer Research Technology Limited | Phthalamides, succinimides and related compounds and their use as pharmaceuticals |
| US20120157387A1 (en) * | 2006-11-28 | 2012-06-21 | Apotex Technologies Inc. | Orally bioavailable d-gamma-glutamyl-d-tryptophan |
| US8557836B2 (en) * | 2008-09-16 | 2013-10-15 | The Trustees Of The University Of Pennsylvania | Spiro-piperidine inhibitors |
| EP2558097B1 (en) * | 2010-04-15 | 2017-10-25 | Biota Scientific Management Pty Ltd | Vapendavir for the alleviation of symptoms of asthma in a subject having a HRV infection |
| TW201217312A (en) * | 2010-09-22 | 2012-05-01 | Gruenenthal Gmbh | Substituted benzamide compounds |
| US20120157382A1 (en) * | 2010-12-21 | 2012-06-21 | Siegfried Krimmer | Pharmaceutical glp-1 compositions having an improved release profile |
| EA032951B1 (ru) * | 2013-04-12 | 2019-08-30 | Общество С Ограниченной Ответственностью "Рсв Терапевтикс" | Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения |
| RU2665688C2 (ru) * | 2013-04-12 | 2018-09-04 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
| RU2552929C1 (ru) * | 2013-11-14 | 2015-06-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний |
-
2014
- 2014-04-10 EA EA201792072A patent/EA032951B1/ru unknown
- 2014-04-10 CN CN201910437243.4A patent/CN110172055B/zh active Active
- 2014-04-10 BR BR122020010204-7A patent/BR122020010204B1/pt active IP Right Grant
- 2014-04-10 EP EP20178489.9A patent/EP3722290B1/en active Active
- 2014-04-10 IL IL266301A patent/IL266301B2/en unknown
- 2014-04-10 JP JP2016507512A patent/JP6529958B2/ja active Active
- 2014-04-10 SG SG10201802647QA patent/SG10201802647QA/en unknown
- 2014-04-10 EA EA201792071A patent/EA033054B1/ru unknown
- 2014-04-10 MX MX2020005738A patent/MX2020005738A/es unknown
- 2014-04-10 EA EA201792597A patent/EA032938B1/ru not_active IP Right Cessation
- 2014-04-10 EA EA201591957A patent/EA031392B1/ru unknown
- 2014-04-10 WO PCT/RU2014/000264 patent/WO2014168522A1/ru active Application Filing
- 2014-04-10 EP EP14782170.6A patent/EP2985282A4/en not_active Withdrawn
- 2014-04-10 CN CN201480032755.8A patent/CN106061962B/zh not_active Expired - Fee Related
- 2014-04-10 SG SG10201802648SA patent/SG10201802648SA/en unknown
- 2014-04-10 CN CN201910437241.5A patent/CN110229140B/zh active Active
- 2014-04-10 BR BR112015025804-2A patent/BR112015025804B1/pt not_active IP Right Cessation
- 2014-04-10 MX MX2020005735A patent/MX2020005735A/es unknown
- 2014-04-10 EP EP20178488.1A patent/EP3725785B1/en active Active
- 2014-04-10 KR KR1020207016268A patent/KR102254315B1/ko active IP Right Grant
- 2014-04-10 KR KR1020207016274A patent/KR102296182B1/ko active IP Right Grant
- 2014-04-10 SG SG11201508394UA patent/SG11201508394UA/en unknown
- 2014-04-10 BR BR122020010210-1A patent/BR122020010210B1/pt not_active IP Right Cessation
- 2014-04-10 AU AU2014251442A patent/AU2014251442A1/en not_active Abandoned
- 2014-04-10 SG SG10201802650WA patent/SG10201802650WA/en unknown
- 2014-04-10 KR KR1020157032457A patent/KR102255929B1/ko active IP Right Grant
- 2014-04-10 US US14/783,911 patent/US9815814B2/en active Active
- 2014-04-10 UA UAA201511008A patent/UA121299C2/uk unknown
- 2014-04-10 CA CA2909057A patent/CA2909057C/en active Active
- 2014-04-10 MX MX2020005736A patent/MX2020005736A/es unknown
- 2014-04-10 CN CN201910437242.XA patent/CN110128406B/zh active Active
- 2014-04-10 MX MX2015014336A patent/MX2015014336A/es unknown
-
2015
- 2015-10-11 IL IL241998A patent/IL241998B/en active IP Right Grant
- 2015-11-10 ZA ZA2015/08278A patent/ZA201508278B/en unknown
-
2016
- 2016-05-10 ZA ZA2016/03108A patent/ZA201603108B/en unknown
- 2016-05-10 ZA ZA2016/03109A patent/ZA201603109B/en unknown
-
2017
- 2017-09-28 US US15/718,295 patent/US10155746B2/en active Active
- 2017-09-28 US US15/718,226 patent/US10155744B2/en active Active
- 2017-09-28 US US15/718,207 patent/US10155743B2/en active Active
- 2017-09-28 US US15/718,316 patent/US10155747B2/en active Active
- 2017-09-28 US US15/718,252 patent/US10155745B2/en active Active
- 2017-09-28 US US15/718,274 patent/US10196377B2/en active Active
-
2018
- 2018-09-27 AU AU2018236805A patent/AU2018236805C1/en not_active Ceased
- 2018-11-07 JP JP2018209574A patent/JP6620324B2/ja active Active
- 2018-11-07 JP JP2018209573A patent/JP6627039B2/ja active Active
- 2018-11-07 JP JP2018209575A patent/JP6843103B2/ja active Active
- 2018-11-15 US US16/192,065 patent/US10377739B2/en active Active
-
2019
- 2019-04-29 IL IL266302A patent/IL266302B/en unknown
- 2019-04-29 IL IL266300A patent/IL266300B/en unknown
-
2020
- 2020-06-02 AU AU2020203630A patent/AU2020203630B2/en active Active
- 2020-06-02 AU AU2020203632A patent/AU2020203632B2/en active Active
- 2020-06-15 AU AU2020203968A patent/AU2020203968B2/en not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL266300B (en) | Antecedents of glutarimide, their use, a pharmaceutical preparation based on them and methods for producing antecedents of glutarimide | |
| HK1215378A1 (zh) | 藥物組合物、治療方法及其用途 | |
| HK1215567A1 (zh) | 五元併六元雜環化合物、其製備方法、藥物組合物和應用 | |
| HK1212980A1 (zh) | 吡啶酮類衍生物、其製備方法及其在醫藥上的應用 | |
| HK1221223A1 (zh) | 二羧酸雙酰胺衍生物、其用途、基於其的藥物組合物和用於生產二羧酸雙酰胺衍生物的方法 | |
| HK1223360A1 (zh) | 新的吲嗪化合物、其製備方法和包含它們的藥物組合物 | |
| EP3012256A4 (en) | HETEROCYCLIC BENZIMIDAZOLE-2-PIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, PROCESS FOR PREPARATION AND USE THEREOF | |
| EP3037099A4 (en) | Pharmaceutical composition, preparation method therefor and use thereof | |
| EP3078659A4 (en) | 3-FURYL-2-CYANO-2-ACRYLAMIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| IL238851A0 (en) | The history of pyrrolidine, pharmaceutical preparations and their uses | |
| HK1212968A1 (zh) | 氨基環丁烷衍生物、其製備方法及其用作藥物的用途 | |
| HUP1300393A2 (en) | Quinazoline derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same |